273 related articles for article (PubMed ID: 17296653)
1. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
Doustdar F; Khosravi AD; Farnia P
Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
[TBL] [Abstract][Full Text] [Related]
7. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
9. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
10. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
[TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
13. Pyrazinamide Susceptibility and
Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
[TBL] [Abstract][Full Text] [Related]
14. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.
Chiu YC; Huang SF; Yu KW; Lee YC; Feng JY; Su WJ
BMC Infect Dis; 2011 Sep; 11():240. PubMed ID: 21910892
[TBL] [Abstract][Full Text] [Related]
17. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
[TBL] [Abstract][Full Text] [Related]
20. [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
Hong CY; Wang F; Liu XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):198-201. PubMed ID: 23856143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]